3.6200
-0.6300
(-14.82%)
As of 11:00:59 AM GMT. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-481.0000
-481.0000
2,140.0000
793.0000
1,583.0000
Investing Cash Flow
-424.0000
-424.0000
-319.0000
-204.0000
-13.0000
Financing Cash Flow
-1,062.0000
-1,062.0000
-209.0000
-400.0000
-146.0000
End Cash Position
2,027.0000
2,027.0000
3,994.0000
2,387.0000
2,210.0000
Capital Expenditure
-237.0000
-237.0000
-319.0000
-204.0000
-13.0000
Repayment of Debt
-824.0000
-824.0000
--
--
--
Free Cash Flow
-718.0000
-718.0000
1,821.0000
589.0000
1,570.0000
12/31/2020 - 10/3/1995
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EZB.BE Enzo Biochem Inc
0.6300
-2.33%
NN6.F NanoRepro AG
1.4200
-4.05%
IDHCl.XC
ESF0.MU Eurofins Scientific SE
50.22
0.00%
GDR.L genedrive plc
2.1500
-4.44%
MVF.AX Monash IVF Group Limited
1.2150
+0.83%
VIMIAN.ST Vimian Group AB (publ)
38.25
+2.41%
DAP.DE Danaher Corporation
237.95
+1.21%
SZLS.TO StageZero Life Sciences Ltd.
0.0400
0.00%
DAP.F Danaher Corporation
237.40
+1.22%